Just How Positive is Piper Jaffray on Henry Schein Inc (NDAQ:HSIC) Following Their Upgrade?

September 17, 2017 - By Migdalia James

  Just How Positive is Piper Jaffray on Henry Schein Inc (NDAQ:HSIC) Following Their Upgrade?

Investors sentiment decreased to 0.81 in 2016 Q4. Its down 0.19, from 1 in 2016Q3. It dropped, as 50 investors sold Henry Schein, Inc. shares while 192 reduced holdings. 70 funds opened positions while 127 raised stakes. 71.97 million shares or 0.99% more from 71.27 million shares in 2016Q3 were reported.

Profund Advsrs Limited Liability Company reported 6,934 shares. Da Davidson holds 0% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 1,217 shares. Whittier Com Of Nevada reported 185 shares stake. Kings Point Capital holds 0.01% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 200 shares. The California-based Montecito Bankshares Tru has invested 0.07% in Henry Schein, Inc. (NASDAQ:HSIC). New York State Teachers Retirement System stated it has 0.06% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Wealthtrust Fairport Ltd Llc has invested 0.03% in Henry Schein, Inc. (NASDAQ:HSIC). Texas Permanent School Fund invested 0.05% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Magnetar Limited Liability Corp invested in 6,606 shares. 241,531 are held by Davis R M. Putnam Invs Limited Liability Com accumulated 11,580 shares. Anderson Hoagland & Com has 0.48% invested in Henry Schein, Inc. (NASDAQ:HSIC). Invesco Limited reported 964,532 shares. Daiwa holds 0% or 2,150 shares in its portfolio. First Manhattan invested in 545 shares.

Since March 17, 2017, it had 0 insider purchases, and 3 selling transactions for $5.09 million activity. $1.71 million worth of stock was sold by RACIOPPI MICHAEL on Monday, March 20. 12,578 shares valued at $2.20 million were sold by BENJAMIN GERALD A on Thursday, May 11. The insider MLOTEK MARK E sold 5,559 shares worth $950,478. $1.60 million worth of Henry Schein, Inc. (NASDAQ:HSIC) was sold by McGlynn Lorelei. Minowitz Robert also sold $1.29M worth of Henry Schein, Inc. (NASDAQ:HSIC) on Friday, May 12.

Henry Schein Inc (NDAQ:HSIC) Stock Upgrade

The rating for shares of Henry Schein Inc (NDAQ:HSIC) were upgraded by analysts at Piper Jaffray from a “Neutral” rating to a “Overweight” rating in a note released on 15 September.

Investors sentiment decreased to 0.81 in 2016 Q4. Its down 0.19, from 1 in 2016Q3. It dropped, as 50 investors sold Henry Schein, Inc. shares while 192 reduced holdings. 70 funds opened positions while 127 raised stakes. 71.97 million shares or 0.99% more from 71.27 million shares in 2016Q3 were reported.

Profund Advsrs Limited Liability Company reported 6,934 shares. Da Davidson holds 0% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 1,217 shares. Whittier Com Of Nevada reported 185 shares stake. Kings Point Capital holds 0.01% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 200 shares. The California-based Montecito Bankshares Tru has invested 0.07% in Henry Schein, Inc. (NASDAQ:HSIC). New York State Teachers Retirement System stated it has 0.06% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Wealthtrust Fairport Ltd Llc has invested 0.03% in Henry Schein, Inc. (NASDAQ:HSIC). Texas Permanent School Fund invested 0.05% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Magnetar Limited Liability Corp invested in 6,606 shares. 241,531 are held by Davis R M. Putnam Invs Limited Liability Com accumulated 11,580 shares. Anderson Hoagland & Com has 0.48% invested in Henry Schein, Inc. (NASDAQ:HSIC). Invesco Limited reported 964,532 shares. Daiwa holds 0% or 2,150 shares in its portfolio. First Manhattan invested in 545 shares.

Since March 17, 2017, it had 0 insider purchases, and 3 selling transactions for $5.09 million activity. $1.71 million worth of stock was sold by RACIOPPI MICHAEL on Monday, March 20. 12,578 shares valued at $2.20 million were sold by BENJAMIN GERALD A on Thursday, May 11. The insider MLOTEK MARK E sold 5,559 shares worth $950,478. $1.60 million worth of Henry Schein, Inc. (NASDAQ:HSIC) was sold by McGlynn Lorelei. Minowitz Robert also sold $1.29M worth of Henry Schein, Inc. (NASDAQ:HSIC) on Friday, May 12.

Henry Schein, Inc. (NASDAQ:HSIC) Ratings Coverage

Among 4 analysts covering Henry Schein Inc. (NDAQ:HSIC), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Henry Schein Inc. has $218 highest and $178 lowest target. $198’s average target is 138.90% above currents $82.88 stock price. Henry Schein Inc. had 4 analyst reports since April 12, 2017 according to SRatingsIntel. Barrington Research maintained Henry Schein, Inc. (NASDAQ:HSIC) on Wednesday, May 10 with “Outperform” rating. The company was upgraded on Monday, August 7 by Northcoast. As per Wednesday, April 12, the company rating was maintained by Craig Hallum. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, May 10 report.

The stock increased 2.86% or $2.31 on September 15, reaching $82.88. About 2.92M shares traded or 104.20% up from the average. Henry Schein, Inc. (NDAQ:HSIC) has risen 4.05% since September 17, 2016 and is uptrending. It has underperformed by 12.65% the S&P500.

Investors wait Henry Schein, Inc. (NASDAQ:HSIC) to report on November, 1. its quarterly earnings Wall Street analysts expect $1.79 EPS, up $0.11 or 6.55 % from last year’s $1.68 same quarter earnings. This translates into $282.93M profit for HSIC giving the stock a 11.58 P/E. This is assuming the current $1.79 EPS is accurate. Henry Schein, Inc.’s Wall Street analysts see 2.29 % EPS growth, taking into account the $1.75 EPS reproted in the previous quarter,

Henry Schein, Inc. is a provider of healthcare services and products primarily to office dental, animal health and medical practitioners. The company has market cap of $13.10 billion. The Firm operates through two divisions: healthcare distribution, and technology and value-added services. It has a 24.25 P/E ratio. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

More notable recent Henry Schein, Inc. (NASDAQ:HSIC) news were published by: Benzinga.com which released: “Looking For Amazon-Proof Stocks? Try Henry Schein” on September 15, 2017, also Prnewswire.com with their article: “Henry Schein Partners With IMF And LUGPA To Raise Awareness Of The Critical …” published on August 31, 2017, Prnewswire.com published: “Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By …” on August 25, 2017. More interesting news about Henry Schein, Inc. (NASDAQ:HSIC) were released by: Prnewswire.com and their article: “Henry Schein MicroMD EMR┬« Earns ONC-Health IT Certification From Drummond …” published on September 08, 2017 as well as Nasdaq.com‘s news article titled: “Henry Schein’s Merritt Buyout to Boost US Veterinary Arm” with publication date: August 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: